Predicting Long-Term Outcome Risk with Tirzepatide: A Post-Hoc Analysis of SURMOUNT-1

First published 05/12/2022

Last updated 14/03/2024

EU PAS number:

EUPAS49988

Study

Planned

Documents

Study protocol

Initial protocol

2022-11193_S-1 Risk Prediction_Protocol_EXPERT response_v2_clean_amended (1)

English (687.35 KB - PDF) View document

Updated protocol

2022-11193_S-1 Risk Prediction_Protocol_EXPERT response_v3_clean

First published: 22/02/2024

English (767.53 KB - PDF) View document

Study results

Study report

Other information

Publications

Study publications

Secondary tabs